Skip to main content

Advertisement

Table 4 Serious adverse events by treatment group

From: Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa

  CQ (N = 79) SP (N = 77) SP – AS (N = 81)
Patients with any SAE, n (%) 15 (19.0) 10 (13.0) 3 (3.7)
- Severe anaemia 3 2 0
- Acute respiration infection 2 2 3
- Seizure 1 1 0
- Pyomyositis 0 1 0
  1. (% calculated on the total number of patients). ‡ Comparison using Fisher's Exact test for SP-AS vs CQ (p = 0.002) and SP-AS vs SP (p = 0.043)